يعرض 1 - 20 نتائج من 9,172 نتيجة بحث عن '(( significant impairment decrease ) OR ( significant ((compared decrease) OR (marked decrease)) ))', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

    منشور في 2025
    "…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
  2. 2

    HFD decreases intermediate-term memory. حسب Tong Yue (6033305)

    منشور في 2025
    "…<p>(A) The survival rate of 10d <i>Canton-S</i> fed with ND or HFD was observed for 7 days. There was no significant decline in the survival rate in flies fed with HFD compared with ND (n = 10 vials, containing 20 flies at each time point). …"
  3. 3

    HFD decreases ITM and alters metabolic homeostasis. حسب Tong Yue (6033305)

    منشور في 2025
    "…The TAG accumulated in the whole body significantly increased under the HFD condition compared to the ND condition. …"
  4. 4

    Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

    منشور في 2025
    الموضوعات:
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. حسب Denis Mustafov (19137870)

    منشور في 2025
    "…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …"
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx حسب Fengwang Xue (22245625)

    منشور في 2025
    "…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …"
  17. 17

    Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx حسب Fengwang Xue (22245625)

    منشور في 2025
    "…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …"
  18. 18

    Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx حسب Fengwang Xue (22245625)

    منشور في 2025
    "…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …"
  19. 19

    Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx حسب Fengwang Xue (22245625)

    منشور في 2025
    "…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …"
  20. 20

    Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx حسب Fengwang Xue (22245625)

    منشور في 2025
    "…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …"